192 related articles for article (PubMed ID: 27765085)
1. Differential Expression of MicroRNAs in Hepatitis C Virus-Mediated Liver Disease Between African Americans and Caucasians: Implications for Racial Health Disparities.
Devhare PB; Steele R; Di Bisceglie AM; Kaplan DE; Ray RB
Gene Expr; 2017 Feb; 17(2):89-98. PubMed ID: 27765085
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of miRNAs in colon cancer between African and Caucasian Americans: implications for cancer racial health disparities.
Li E; Ji P; Ouyang N; Zhang Y; Wang XY; Rubin DC; Davidson NO; Bergamaschi R; Shroyer KR; Burke S; Zhu W; Williams JL
Int J Oncol; 2014 Aug; 45(2):587-94. PubMed ID: 24865442
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
6. Genomic scale analysis of racial impact on response to IFN-alpha.
Pos Z; Selleri S; Spivey TL; Wang JK; Liu H; Worschech A; Sabatino M; Monaco A; Leitman SF; Falus A; Wang E; Alter HJ; Marincola FM
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):803-8. PubMed ID: 20080756
[TBL] [Abstract][Full Text] [Related]
7. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
Thibault PA; Wilson JA
Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
El-Serag HB; Kramer J; Duan Z; Kanwal F
Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
[TBL] [Abstract][Full Text] [Related]
9. Racial Disparities in Hepatitis C Treatment Eligibility.
Sims OT; Pollio DE; Hong BA; North CS
Ann Hepatol; 2017; 16(4):530-537. PubMed ID: 28611273
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNAs in hepatitis C virus replication and related liver diseases.
Lee CH; Kim JH; Lee SW
J Microbiol; 2014 Jun; 52(6):445-51. PubMed ID: 24871972
[TBL] [Abstract][Full Text] [Related]
11. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
12. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
Bulfoni M; Pravisani R; Dalla E; Cesselli D; Hidaka M; Di Loreto C; Eguchi S; Baccarani U
J Med Virol; 2021 Aug; 93(8):4992-5000. PubMed ID: 33818800
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.
Liao TL; Chen YM; Hsieh SL; Tang KT; Chen DY; Yang YY; Liu HJ; Yang SS
mBio; 2021 Dec; 12(6):e0276421. PubMed ID: 34724826
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.
Shrivastava S; Petrone J; Steele R; Lauer GM; Di Bisceglie AM; Ray RB
Hepatology; 2013 Sep; 58(3):863-71. PubMed ID: 23390075
[TBL] [Abstract][Full Text] [Related]
15. Complex interactions between microRNAs and hepatitis B/C viruses.
Fan HX; Tang H
World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
[TBL] [Abstract][Full Text] [Related]
16. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.
Oliveira KG; Malta FM; Nastri AC; Widman A; Faria PL; Santana RA; Alves VA; Carrilho FJ; Pinho JR
Med Microbiol Immunol; 2016 Apr; 205(2):111-7. PubMed ID: 26272127
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer clinical and molecular analysis of racial disparities.
Lara OD; Wang Y; Asare A; Xu T; Chiu HS; Liu Y; Hu W; Sumazin P; Uppal S; Zhang L; Rauh-Hain JA; Sood AK
Cancer; 2020 Feb; 126(4):800-807. PubMed ID: 31730714
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
[TBL] [Abstract][Full Text] [Related]
19. microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.
Spaniel C; Honda M; Selitsky SR; Yamane D; Shimakami T; Kaneko S; Lanford RE; Lemon SM
PLoS One; 2013; 8(10):e76867. PubMed ID: 24130799
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.
Oksuz Z; Serin MS; Kaplan E; Dogen A; Tezcan S; Aslan G; Emekdas G; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2015 Mar; 42(3):713-20. PubMed ID: 25391771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
